10/5/2021 6:48:03 AM
NanoViricides Presents Update Of Pan-Coronavirus COVID-19 Drug Development Program At Benzinga Healthcare Conference
9/22/2021 6:47:55 AM
NanoViricides Reports On Advantages Gained By Remdesivir Encapsulation Within Its COVID-19 Candidate NV-CoV-2
9/14/2021 6:58:33 AM
NanoViricides Completes Licensing For Coronavirus Field For Drug Commercialization From TheraCour Pharma